Citations

Clear

2 citation(s) found for "Shilatifard, Ali".

TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas
González-Buendía, Edgar , Zhao, Junfei , Mukherjee, Subhas, Zhang, Daniel Y. , Feldstein, Eric , Kang, Seong Jae , Lee-Chang, Catalina , Mahajan, Aayushi , Chen, Li , Karan, Charles , Magnuson, Lisa, Marshall, Stacy A. , Mohyeldin, Ahmed, Nakano, Ichiro , Bansal, Mukesh , James, C. David , Ahmed, Atique U. , Canoll, Peter , Shilatifard, Ali , Zhang, Daniel , Realubit, Ronald , Karan, Charles , Ahmed, Atique , Sonabend, Adam M , Wang, Lu , Mukherjee, Subhas, Arrieta, Victor Andrés , KANE, JOSHUA ROBERT , Horbinski, Craig , Sarkaria, Jann N. , Brat, Daniel J. , Rabadán, Raúl

Mayo Clinic

Clinical Cancer Research | August 25, 2021 | Volume: 27 | Issue: 20 | Pages: 5669-5680

10.1158/1078-0432.ccr-21-0312 | PMID 34433651 Get It

Abstract Purpose: The epigenetic mechanisms involved in transcriptional regulation leading to malignant phenotype in gliomas remains poorly understood. Topoisomerase IIB (TOP2B), an enzyme that decoils and releases torsional forces in DNA, is overexpressed in a subset of gliomas. Therefore, we investigated its role in epigenetic regulation in these tumors. Experimental Design: To investigate the role of TOP2B in epigenetic regulation in gliomas, we performed paired chromatin immunoprecipitation sequencing for TOP2B and RNA-sequencing analysis of glioma cell lines with and without TOP2B inhibition and in human glioma specimens. These experiments were complemented with assay for transposase-accessible chromatin using sequencing, gene silencing, and mouse xenograft experiments to investigate the function of TOP2B and its role in glioma phenotypes. Results: We discovered that TOP2B modulates transcription of multiple oncogenes in human gliomas. TOP2B regulated transcription only at sites where it was enzymatically active, but not at all native binding sites. In particular, TOP2B activity localized in enhancers, promoters, and introns of PDGFRA and MYC, facilitating their expression. TOP2B levels and genomic localization was associated with PDGFRA and MYC expression across glioma specimens, which was not seen in nontumoral human brain tissue. In vivo, TOP2B knockdown of human glioma intracranial implants prolonged survival and downregulated PDGFRA. Conclusions: Our results indicate that TOP2B activity exerts a pleiotropic role in transcriptional regulation of oncogenes in a subset of gliomas promoting a proliferative phenotype.
Precancer Atlas to Drive Precision Prevention Trials
Spira, Avrum, Yurgelun, Matthew B., Alexandrov, Ludmil, Rao, Anjana, Bejar, Rafael, Polyak, Kornelia, Giannakis, Marios, Shilatifard, Ali, Finn, Olivera J., Dhodapkar, Madhav, Kay, Neil E., Braggio, Esteban, Vilar, Eduardo, Mazzilli, Sarah A., Rebbeck, Timothy R., Garber, Judy E., Velculescu, Victor E., Disis, Mary L., Wallace, Douglas C., Lippman, Scott M., Braggio, Esteban , Velculescu, Victor E. , Alexandrov, Ludmil B. , Spira, Avrum, Yurgelun, Matthew B., Alexandrov, Ludmil, Rao, Anjana, Bejar, Rafael, Polyak, Kornelia, Giannakis, Marios, Shilatifard, Ali, Finn, Olivera J., Dhodapkar, Madhav, Kay, Neil E., Braggio, Esteban, Vilar, Eduardo, Mazzilli, Sarah A., Rebbeck, Timothy R., Garber, Judy E., Velculescu, Victor E., Disis, Mary L., Wallace, Douglas C., Lippman, Scott M., Braggio, Esteban , Alexandrov, Ludmil B

Mayo Clinic

Cancer Research | April 3, 2017 | Volume: 77 | Issue: 7 | Pages: 1510-1541

10.1158/0008-5472.can-16-2346 | PMID 28373404 Get It

Abstract Cancer development is a complex process driven by inherited and acquired molecular and cellular alterations. Prevention is the holy grail of cancer elimination, but making this a reality will take a fundamental rethinking and deep understanding of premalignant biology. In this Perspective, we propose a national concerted effort to create a Precancer Atlas (PCA), integrating multi-omics and immunity – basic tenets of the neoplastic process. The biology of neoplasia caused by germline mutations has led to paradigm-changing precision prevention efforts, including: tumor testing for mismatch repair (MMR) deficiency in Lynch syndrome establishing a new paradigm, combinatorial chemoprevention efficacy in familial adenomatous polyposis (FAP), signal of benefit from imaging-based early detection research in high-germline risk for pancreatic neoplasia, elucidating early ontogeny in BRCA1-mutation carriers leading to an international breast cancer prevention trial, and insights into the intricate germline-somatic-immunity interaction landscape. Emerging genetic and pharmacologic (metformin) disruption of mitochondrial (mt) respiration increased autophagy to prevent cancer in a Li-Fraumeni mouse model (biology reproduced in clinical pilot) and revealed profound influences of subtle changes in mt DNA background variation on obesity, aging, and cancer risk. The elaborate communication between the immune system and neoplasia includes an increasingly complex cellular microenvironment and dynamic interactions between host genetics, environmental factors, and microbes in shaping the immune response. Cancer vaccines are in early murine and clinical precancer studies, building on the recent successes of immunotherapy and HPV vaccine immune prevention. Molecular monitoring in Barrett's esophagus to avoid overdiagnosis/treatment highlights an important PCA theme. Next generation sequencing (NGS) discovered age-related clonal hematopoiesis of indeterminate potential (CHIP). Ultra-deep NGS reports over the past year have redefined the premalignant landscape remarkably identifying tiny clones in the blood of up to 95% of women in their 50s, suggesting that potentially premalignant clones are ubiquitous. Similar data from eyelid skin and peritoneal and uterine lavage fluid provide unprecedented opportunities to dissect the earliest phases of stem/progenitor clonal (and microenvironment) evolution/diversity with new single-cell and liquid biopsy technologies. Cancer mutational signatures reflect exogenous or endogenous processes imprinted over time in precursors. Accelerating the prevention of cancer will require a large-scale, longitudinal effort, leveraging diverse disciplines (from genetics, biochemistry, and immunology to mathematics, computational biology, and engineering), initiatives, technologies, and models in developing an integrated multi-omics and immunity PCA – an immense national resource to interrogate, target, and intercept events that drive oncogenesis. Cancer Res; 77(7); 1510–41. ©2017 AACR.